author-photo

Masahiro Aoki

Chugai Pharmaceutical Co.

19

Papers

349

Citations

Citation Trend

Filter By

Papers (15) Sort By

Journal Conference Others

Acquired JHDM1D–BRAF Fusion Confers Resistance to FGFR Inhibition in FGFR2-Amplified Gastric Cancer

2018 Molecular Cancer Therapeutics
Show All
- Source
- Cite
- Save
Citations (6)
An anti–glypican 3/CD3 bispecific T cell–redirecting antibody for treatment of solid tumors

2017 Science Translational Medicine
Show All
- Source
- Cite
- Save
Citations (94)
Combining Onartuzumab with Erlotinib Inhibits Growth of Non-Small Cell Lung Cancer with Activating EGFR Mutations and HGF Overexpression

2015 Molecular Cancer Therapeutics
Show All
- Source
- Cite
- Save
Citations (21)
Abstract 123: Mechanism of oncogenic signal activation by the novel fusion kinase FGFR3-BAIAP2L1

2015 Cancer Research
Show All
- Source
- Cite
- Save
Citations (2)
Combining Onartuzumab with Erlotinib Inhibits Growth of Non-Small Cell Lung Cancer with Activating EGFR Mutations and HGF

2014
Show All
- Source
- Cite
- Save
Citations (0)
Abstract 5252: Inhibition of FGFR3-BAIAP2L1 fusion kinase oncogenic potential by CH5183284/Debio 1347, a compound that inhibits FGFR3 kinase activity constitutively activated by BAIAP2L1 BAR domain dimerization

2014 Cancer Research
Show All
- Source
- Cite
- Save
Citations (2)
Abstract A41: Pre-clinical investigation of predictive biomarkers for drug candidates using a molecularly profiled large cancer cell line panel.

2013 Molecular Cancer Therapeutics
Show All
- Source
- Cite
- Save
Citations (0)
Enantioselective synthesis of derivatives and structure-activity relationship study in the development of NA255 as a novel host-targeting anti-HCV agent.

2013 Bioorganic & Medicinal Chemistry Letters
Show All
- Source
- Cite
- Save
Citations (4)
Abstract 2728: Onartuzumab (MetMAb) restores sensitivity to erlotinib in EGFR mutant NSCLC cells expressing HGF

2012 Cancer Research
Show All
- Source
- Cite
- Save
Citations (2)
Enantioselective total synthesis of derivatives of NA255, a novel host-targeting anti-HCV agent

2009
Show All
- Source
- Cite
- Save
Citations (0)